Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine plus naloxone for methadone poisoning
IRCT20210222050462N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetylcysteine and naloxone in methadone intoxication (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: AST, ALT and 17 more. Started May 2021; status: completed.
02
Drugs
acetylcysteinenaloxone
03
Conditions
methadone intoxication
Beyond the preview
Go deeper on IRCT20210222050462N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210222050462N1.